Liste de publications de Deborah Konopnicki
Articles dans des revues avec comité de lecture (39)
1.
Touré, Y., Martin, C., Necsoi, C. V., Delforge, M., Konopnicki, D., & Dauby, N. (2025). Experience of maternal immunization among women living with HIV in Belgium: A mixed-methods study. Preventive medicine reports, 54, 103107. doi:10.1016/j.pmedr.2025.1031072.
Taton, M., Willems, F., Widomski, C., Georges, D., Martin, C., Jiang, Y., Renard, K., Konopnicki, D., Cogan, A., Necsoi, C. V., Matagne, A., De Wit, S., Ackerman, M. M., Marchant, A., & Dauby, N. (2024). HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy. EBioMedicine, 104, 105179. doi:10.1016/j.ebiom.2024.1051793.
Filiz, M., Erdem, H., Ankarali, H., Puca, E., Ruch, Y., Santos, L., Fasciana, T., Giammanco, A. M., Ghanem-Zoubi, N., Argemi, X., Hansmann, Y., Guner, R., Tonziello, G., Mazzucotelli, J.-P., Como, N., Kose, S., Batirel, A., Inan, A., Tulek, N., Pekok, A. U., Khan, E. A., Iyisoy, A., Meric-Koc, M., Kaya-Kalem, A., Martins, P. P., Hasanoglu, I., Silva-Pinto, A., Oztoprak, N., Duro, R., Almajid, F., Dogan, M., Dauby, N., Gunst, J. D., Tekin, R., Konopnicki, D., Petrosillo, N., Bozkurt, I., Al Ramahi, J. W., Popescu, C., Balkan, I. I., Ozer-Balin, S., Zupanc, T. L., Cascio, A., Dumitru, I. M., Erdem, A., Ersoz, G., Tasbakan, M., Ajamieh, O. A., Sirmatel, F., Florescu, S., Gulsun, S., Ozkaya, H. D., Sari, S., Tosun, S., Avci, M., Cag, Y., Celebi, G., Sagmak-Tartar, A., Karakus, S., Sener, A., Dedej, A., Oncu, S., Del Vecchio, R. F., Ozturk-Engin, D., & Agalar, C. (2024). Identifying risk factors for blood culture negative infective endocarditis: An international ID-IRI study. New Microbes and New Infections, 60-61, 101453. doi:10.1016/j.nmni.2024.1014534.
Ingle, S. S., Miró, J. M., May, M. M., Cain, L. L., Schwimmer, C., Zangerle, R., Sambatakou, H., Cazanave, C., Reiss, P., Brandes, V., Bucher, H. H., Sabin, C., Vidal, F., Obel, N., Mocroft, A., Wittkop, L., d'Arminio Monforte, A., Torti, C., Mussini, C., Furrer, H., Konopnicki, D., Teira, R., Saag, M., Crane, H. H., Moore, R. R., Jacobson, J. J., Mathews, W. C., Geng, E., Eron, J. J., Althoff, K. N., Kroch, A., Lang, R., Gill, M., & Sterne, J. J. (2023). Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study. Clinical infectious diseases, 77(1), 64-73. doi:10.1093/cid/ciad1225.
Bukkems, V., Necsoi, C. V., Hidalgo-Tenorio, C., Garcia, C., Alba-Alejandre, I., Weiss, F., Lambert, J. S., Van Hulzen, A., Richel, O., Te Brake, L. L., Van Der Meulen, E., Burger, D., Konopnicki, D., & Colbers, A. P. H. (2022). Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network. Clinical infectious diseases, 75(4), 623-629. doi:10.1093/cid/ciab10106.
Malinverni, S., Lazzaroni, S., Nuňez, M., Preseau, T., Cotton, F., Martiny, D., Bouazza, F.-Z., Collot, V., Konopnicki, D., Alard, S., & Bartiaux, M. (2022). Diagnostic Accuracy of Procalcitonin upon Emergency Department Admission during SARS-CoV-2 Pandemic. Antibiotics, 11(9). doi:10.3390/antibiotics110911417.
Poncelet, A., Ruelle, L., Konopnicki, D., Miendje Deyi, Y. V., & Dauby, N. (2021). Saccharomyces cerevisiae fungemia: risk factors, outcome and links with S. boulardii-containing probiotic administration. Infectious Diseases Now. doi:10.1016/j.idnow.2020.12.0038.
Vanhomwegen, C., Veliziotis, I., Malinverni, S., Konopnicki, D., Dechamps, P., Claus, M., Roman, A., Cotton, F., & Dauby, N. (2021). Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit. Irish journal of medical science. doi:10.1007/s11845-020-02485-z10.
Bukkems, V., Necsoi, C. V., Tenorio, C. H., Garcia, C., Rockstroh, J., Schwarze-Zander, C., Lambert, J. S., Burger, D., Konopnicki, D., & Colbers, A. P. H. (2020). Clinically significant lower elvitegravir exposure during the third trimester of pregnant patients living with human immunodeficiency virus: Data from the pharmacokinetics of antiretroviral agents in hiv-infected pregnant women (PANNA) network. Clinical infectious diseases, 71(10), E714-E717. doi:10.1093/cid/ciaa48811.
Veliziotis, I., Roman, A., Martiny, D., Schuldt, G., Claus, M., Dauby, N., Van den Wijngaert, S., Martin, C., Nasreddine, R., Perandones, C., Mahieu, R., Swaan, C., Van Praet, S., Konopnicki, D., Morales, M. A., Malvy, D., Stevens, E., Dechamps, P., Vlieghe, E., Vandenberg, O., Günther, S., & Gerard, M. (2020). Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020. Emerging infectious diseases, 26(7), 1562-1566. doi:10.3201/eid2607.20027512.
Thémans, P., Dauby, N., Schrooyen, L., Lebout, F., Delforge, M.-L., Nasreddine, R., Libois, A., Payen, M.-C., Konopnicki, D., Wuillaume, F., Lescrainier, C., Verlinden, V., Dogné, J.-M., Hamdani, J., & Musuamba, F. T. (2020). Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps. British journal of clinical pharmacology. doi:10.1111/bcp.14436